Inventor
MAGGIO EDWARD T
US58 patents
⚠️ This page may combine multiple inventors who share the name “MAGGIO EDWARD T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MAGGIO EDWARD T
14 patentsUS8226949B2Jul 24, 2012
Stabilizing alkylglycoside compositions and methods thereof
MAGGIO EDWARD T32 citations96
US8133863B2Mar 13, 2012
Stabilizing alkylglycoside compositions and methods thereof
MAGGIO EDWARD T38 citations96
US4397956AAug 9, 1983
Means for monitoring the status of control of ketoacidosis-prone diabetics
MAGGIO EDWARD T56 citations96
US8268791B2Sep 18, 2012
Alkylglycoside compositions for drug administration
MAGGIO EDWARD T36 citations93
US8084022B2Dec 27, 2011
Stabilizing alkylglycoside compositions and methods thereof
MAGGIO EDWARD T19 citations93
US8927497B2Jan 6, 2015
Absorption enhancers for intranasal administration
MAGGIO EDWARD T11 citations84
US8883728B2Nov 11, 2014
Intranasal administration of active agents to the central nervous system
MAGGIO EDWARD T5 citations84
US8846044B2Sep 30, 2014
Stabilizing alkylglycoside compositions and methods thereof
MAGGIO EDWARD T7 citations84
US8772231B2Jul 8, 2014
Stabilizing alkylglycoside compositions and methods thereof
MAGGIO EDWARD T12 citations84
US8642564B2Feb 4, 2014
Compositions for drug administration
MAGGIO EDWARD T11 citations84
US8440631B2May 14, 2013
Compositions for drug administration
MAGGIO EDWARD T7 citations84
US8173594B2May 8, 2012
Stabilizing alkylglycoside compositions and methods thereof
MAGGIO EDWARD T13 citations84
US8076290B2Dec 13, 2011
Stabilizing alkylglycoside compositions and methods thereof
MAGGIO EDWARD T12 citations84
US8551468B2Oct 8, 2013
Absorption enhancers for intranasal interferon administration
MAGGIO EDWARD T4 citations74
AEGIS THERAPEUTICS LLC
13 patentsUS7998927B2Aug 16, 2011
Stabilizing alkylglycoside compositions and methods thereof
AEGIS THERAPEUTICS LLC38 citations96
US9642913B2May 9, 2017
Pharmaceutical composition including alkyl glycoside and an anti-seizure agent
AEGIS THERAPEUTICS LLC13 citations93
US10682414B2Jun 16, 2020
Intranasal epinephrine formulations and methods for the treatment of disease
AEGIS THERAPEUTICS LLC10 citations92
US11918655B2Mar 5, 2024
Intranasal epinephrine formulations and methods for the treatment of disease
AEGIS THERAPEUTICS LLC5 citations85
US11717571B2Aug 8, 2023
Intranasal epinephrine formulations and methods for the treatment of disease
AEGIS THERAPEUTICS LLC6 citations85
US11744895B2Sep 5, 2023
Intranasal epinephrine formulations and methods for the treatment of disease
AEGIS THERAPEUTICS LLC3 citations84
US11191838B2Dec 7, 2021
Intranasal epinephrine formulations and methods for the treatment of disease
AEGIS THERAPEUTICS LLC8 citations84
US11173209B2Nov 16, 2021
Compositions for drug administration
AEGIS THERAPEUTICS LLC6 citations84
US10576156B2Mar 3, 2020
Compositions for drug administration
AEGIS THERAPEUTICS LLC10 citations84
US10265402B2Apr 23, 2019
Absorption enhancers for drug administration
AEGIS THERAPEUTICS LLC13 citations84
US9446134B2Sep 20, 2016
Stabilizing alkylglycoside compositions and methods thereof
AEGIS THERAPEUTICS LLC4 citations84
US12324838B2Jun 10, 2025
Intranasal epinephrine formulations and methods for the treatment of disease
AEGIS THERAPEUTICS LLC3 citations74
US10046025B2Aug 14, 2018
Stabilizing alkylglycoside compositions and methods thereof
AEGIS THERAPEUTICS LLC3 citations73
SYNBIOTICS CORP
4 patentsUS4859610AAug 22, 1989
Immunoassay incubation device
SYNBIOTICS CORP122 citations96
US4828981AMay 9, 1989
Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
SYNBIOTICS CORP56 citations96
US5079142AJan 7, 1992
Orthogonal flow immunoassays and devices
SYNBIOTICS CORP107 citations94
US4789631ADec 6, 1988
Immunoassay for anti-dirofilaria immitis antibody
SYNBIOTICS CORP34 citations93
NEURELIS INC
4 patentsUS12337061B2Jun 24, 2025
Administration of benzodiazepine compositions
NEURELIS INC2 citations73
US12324852B2Jun 10, 2025
Administration of benzodiazepine compositions
NEURELIS INC2 citations73
US12268664B1Apr 8, 2025
Administration of benzodiazepine compositions
NEURELIS INC3 citations73
US11793786B2Oct 24, 2023
Administration of benzodiazepine compositions
NEURELIS INC2 citations71
SYVA CO
3 patentsSYVA
2 patentsAEGIS THERAPEUTICS INC
2 patentsCARTT STEVE
2 patentsQUEST DIAGNOSTICS INVEST INC
1 patentINT DIAGNOSTIC TECH
1 patentBAXTER TRAVENOL LAB
1 patentHALE BIOPHARMA VENTURES LLC
1 patentKARLOV VALERI I
1 patentOPIANT PHARMACEUTICALS INC
1 patentShowing the top 50 of 58 patents by PatentIndex Score.